SCHEMBL30204539

SCHEMBL30204539

Cn1cnc2cc(C(=O)O)ccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.49
KDM4E B2RXH2 1/20 0.47
HPGD P15428 3/20 0.46
IP6K1 Q92551 1/20 0.46
FGFR1 P11362 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM2B Q8NHM5 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
GAA P10253 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
TSHR P16473 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
AKR1B1 P15121 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2040732 1.00 HCAR3 (0.49) HCAR3KDM4EHPGDIP6K1FGFR1
SCHEMBL4181343 0.88 KDM4E (0.57) HCAR3KDM4EHPGDIP6K1FGFR1
SCHEMBL29606390 0.88 KDM4E (0.57) HCAR3KDM4EHPGDIP6K1FGFR1
SCHEMBL2040470 0.86 KDM4E (0.46) KDM4EHPGDIP6K1L3MBTL1ALDH1A1
SCHEMBL2611376 0.84 HDAC6 (0.47) KDM4EHPGDIP6K1L3MBTL1ALDH1A1
SCHEMBL9919053 0.80 L3MBTL1 (0.41) KDM4EHPGDIP6K1L3MBTL1ALDH1A1
SCHEMBL30186355 0.79 ESR1 (0.62) KDM4EHPGDIP6K1L3MBTL1ALDH1A1
SCHEMBL599310 0.79 HCAR3 (0.65) HCAR3HPGDFGFR1ALDH1A1LMNA
SCHEMBL26783285 0.78 JMJD6 (0.49) KDM4EHPGDIP6K1L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL7330424 0.78 HCAR3 (0.63) HCAR3HPGDFGFR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337662-A1 C-LINKED INHIBITORS OF ENL/AF9 YEATS Bridge Medicines (US) 2024-03-20 EP disclosed
WO-2022240830-A1 C-LINKED INHIBITORS OF ENL/AF9 YEATS BRIDGE MEDICINES (US) 2022-11-17 WO disclosed